48,830
edits
Difference between revisions of "Classification of urothelial carcinoma by immunohistochemistry"
Jump to navigation
Jump to search
Classification of urothelial carcinoma by immunohistochemistry (view source)
Revision as of 15:36, 12 January 2022
, 15:36, 12 January 2022no edit summary
| Line 20: | Line 20: | ||
*p16. | *p16. | ||
Notes: | |||
*Twenty percent of the tumour cells is considered the cut-off for ''positive'' and ''negative''.<ref name=pmid34103388/> | *Twenty percent of the tumour cells is considered the cut-off for ''positive'' and ''negative''.<ref name=pmid34103388/> | ||
*GATA3 ''positive'' and CK5/6 ''positive'' cases are classified as ''luminal''.<ref name=pmid34103388/> | |||
*GATA3 ''negative'' and CK5/6 ''negative'' are ''unclassified''.<ref name=pmid34103388/> | |||
==Sign out== | ==Sign out== | ||
| Line 35: | Line 38: | ||
The immunoprofile (CK5/6 POSITIVE, GATA3 negative) is in keeping with UROTHELIAL CARCINOMA, BASAL TYPE. | The immunoprofile (CK5/6 POSITIVE, GATA3 negative) is in keeping with UROTHELIAL CARCINOMA, BASAL TYPE. | ||
</pre> | </pre> | ||
==See also== | ==See also== | ||